Amgen Give Back Worth ~$3/Share to Cytokinetics (CYTK) - Mizuho
Tweet Send to a Friend
Mizuho Securities analyst Salim Syed reiterated a Buy rating and $31.00 price target on Cytokinetics (NASDAQ: CYTK), saying Amgen's give ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
